Skip to main content
. 2023 Nov 10;41(12):3511–3518. doi: 10.1007/s00345-023-04691-7

Table 2.

Sensitivity to change of the EPIC-50 and the EPIC-26 by treatment group

Domains and items Mean (SD) at baseline (T0) Mean (SD) at 12 months (T1) Mean difference (SD) (T1 – T0) Cohen’s Effect Size
EPIC-26 EPIC-50 EPIC-26 EPIC-50 EPIC-26 EPIC-50 EPIC-26 EPIC-50
Radical prostatectomy n = 95 n = 79 n = 95 n = 79 n = 95 n = 79 n = 95 n = 79
Urinary incontinence 93.9 (14.9) 94.3 (16.0) 60.3 (32.3) 59.7 (31.9) − 33.6 (0.0)* − 34.6 (34.7)* 2.25 2.16
Urinary irritative/obstructive 79.9 (19.8) 89.6 (15.8) 80.6 (21.5) 85.5 (20.4) 0.7 (35.0) − 4.1 (22.2) 0.04 0.26
Bowel 96.5 (8.6) 98.4 (4.3) 89.4 (21.8) 95.0 (11.9) − 7.1 (24.5)* − 3.4 (12.0)* 0.83 0.78
Sexual 68.0 (28.4) 71.6 (17.1) 40.9 (28.9) 53.4 (25.1) − 27.1 (22.7)* − 18.3 (24.6)* 0.95 1.07
Hormonal 85.3 (13.1) 88.9 (11.4) 81.6 (26.9) 89.2 (15.8) − 3.8 (32.7) 0.3 (14.9) 0.29 0.03
External radiotherapy n = 115 n = 170 n = 115 n = 170 n = 115 n = 170 n = 115 n = 170
Urinary incontinence 86.9 (20.6) 86.1 (21.5) 85.0 (23.3) 87.7 (21.4) − 1.9 (25.6) 1.7 (21.2) 0.09 0.08
Urinary irritative/obstructive 76.1 (19.8) 85.8 (14.9) 76.9 (23.7) 83.2 (17.2) 0.8 (0.0) − 2.6 (16.9) 0.04 0.17
Bowel 93.5 (13.6) 97.5 (6.2) 87.0 (21.9) 90.7 (15.1) − 6.5 (21.1)* − 6.7 (15.4)* 0.48 1.09
Sexual 34.4 (28.9) 41.9 (19.2) 21.7 (17.5) 36.2 (14.2) − 12.7 (25.9)* − 5.8 (16.1)* 0.44 0.30
Hormonal 77.0 (21.8) 81.1 (15.2) 61.9 (31.2) 75.1 (20.8) − 15.1 (24.1)* − 6.0 (19.6)* 0.69 0.40

*p value was estimated with paired Student’s t test for each subsample and EPIC version